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Translocation of the Na+/H+ exchanger 1 (NHE1) in cardiomyocyte
responses to insulin and energy-status signalling
Scott P. LAWRENCE1, Geoffrey D. HOLMAN2 and Franc ¸oise KOUMANOV
Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, U.K.
The Na
+/H
+ exchanger NHE1 is a highly regulated membrane
protein that is required for pH homoeostasis in cardiomyocytes.
The activation of NHE1 leads to proton extrusion, which is
essential for counteracting cellular acidity that occurs following
increased metabolic activity or ischaemia. The activation of
NHE1 intrinsic catalytic activity has been well characterized
and established experimentally. However, we have examined
in the present study whether a net translocation of NHE1 to
the sarcolemma of cardiomyocytes may also be involved in the
activation process. We have determined the distribution of NHE1
by means of immunoﬂuorescence microscopy and cell-surface
biotinylation. We have discovered changes in the distribution
of NHE1 that occur when cardiomyocytes are stimulated with
insulin that are PI3K (phosphoinositide 3-kinase)-dependent.
Translocation of NHE1 also occurs when cardiomyocytes
are challenged by hypoxia, or inhibition of mitochondrial
oxidative metabolism or electrically induced contraction, but
these responses occur through a PI3K-independent process.
As the proposed additional level of control of NHE1 through
translocation was unexpected, we have compared this process
with the well-established translocation of the glucose transporter
GLUT4. In immunoﬂuorescence microscopy comparisons, the
translocation of NHE1 and GLUT4 to the sarcolemma that occur
in response to insulin appear to be very similar. However, in
basal unstimulated cells the two proteins are mainly located,
with the exception of some co-localization in the perinuclear
region, in distinct subcellular compartments. We propose that the
mechanismsoftranslocationofNHE1andGLUT4arelinkedsuch
that they provide spatially and temporally co-ordinated responses
to cardiac challenges that necessitate re-adjustments in glucose
transport, glucose metabolism and cell pH.
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INTRODUCTION
The mammalian NHE (Na
+/H
+ exchanger) family of proteins
plays an important role in maintenance of pHi (intracellular pH)
[1]. Nine isoforms have been described in mammalian genomes.
NHEs 1 and 6–9 have a ubiquitous expression and NHEs 2–5
have selective tissue expression [2]. NHE2 and NHE3 are
predominantly expressed in apical membranes of kidney and
intestinalepithelialcells[3,4],whereasNHE4ishighlyexpressed
in the stomach [5]. NHE5 is almost exclusively expressed in
the brain, although low levels of expression are also reported
in spleen, testes and skeletal muscles [6,7]. In the mammalian
myocardium, the only plasma membrane isoform is NHE1, and
this exchanger plays a crucial role in the maintenance of pHi
in healthy cells and impairment in its function is associated
with disease states [8]. NHE1 activity is primarily regulated by
decreases in pHi and maximal catalytic activity of the transporter
is achieved at pHi 6.5 or less [9,10]. NHE1 has been directly
implicated in, and has been found to be associated with, damage
causedbyischaemia/reperfusioninjuriesandbyhypertrophy[11].
For these reasons, NHE1 is a major pharmacological target for
development of cardioprotective drugs [12].
NHE1 has been described as a relatively immobile actin-
anchored plasma membrane protein [13,14]. In many tissues,
NHE1 activity is stimulated by growth and hormonal factors,
including serum, EGF (epidermal growth factor) and insulin,
which leads to proton extrusion and a transient cell alkalinization
[15–18]. Hormonal stimulations have been linked to direct
phosphorylation of NHE1 by protein kinases, including
ERK (extracellular-signal-regulated kinase) 1/2, p160ROCK
(p160 Rho-associated kinase), p38 MAPK (mitogen-activated
protein kinase), p90 ribosomal S6K (S6 kinase), CaMKII
(Ca
2+/calmodulin-dependent protein kinase II) and Akt, and to
dephosphorylationdependentupontheproteinphosphatasesPP1,
PP2A and SHP-2 (Src homology 2 domain-containing protein
tyrosine phosphatase 1/2). The changes in phosphorylation
are thought to modulate the catalytic activity of the
exchanger, possibly through altered interaction of the C-terminal
cytoplasmic tail of NHE1 with the actin cytoskeleton (reviewed
in [1,8]).
Previous studies on P-type transporters including the Na
+/K
+
ATPase [19,20] have revealed that, in addition to regulation
via changes in intrinsic catalytic activity, changes in activity
are also associated with translocation of these proteins from
reservoir compartments within the cell to sites where the ion
channelactivitybecomesfunctionallyimportant.Phosphorylation
of aquaporin 2 in the kidney appears to be critical both for
initiating translocation and determining the cellular compartment
to which translocation occurs [21]. It therefore seems pertinent to
determine whether, in addition to the well-established control via
phosphorylation-dependent changes in catalytic activity, NHE1
activity could also be regulated by translocation.
Abbreviations used: AMPK, AMP-activated protein kinase; CaMKII, Ca2+/calmodulin-dependent protein kinase II; ERK, extracellular-signal-regulated
kinase;GLUT4,glucosetransporterisoform4;GST,glutathionetransferase;HA,haemagglutinin;KRH,Krebs-Ringer-Hepes;LcH, Lensculinaris agglutinin;
NHE, Na+/H+ exchanger; pHi, intracellular pH; PI3K, phosphoinositide 3-kinase; TBS, Tris-buffered saline.
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The translocation process and its underlying mechanisms have
been most extensively studied for GLUT4 (glucose transporter
isoform 4), which is regulated by insulin action, and also
in response to changes in the cell energy status. Cellular
responses to insulin, but not to changes in cell energy status,
are mediated through PI3K (phosphoinositide 3-kinase). Cardiac
cell stimulation following hypoxia and inhibition of oxidative
mitochondrial metabolism culminate in GLUT4 translocation
that is initiated by, or dependent upon, signalling-induced
changes in AMPK (AMP-activated protein kinase). The GLUT4
translocation mediated through AMPK is functionally important
as the resultant increase in cellular glucose transport can lead to
the readjustment and replenishment of cell glucose metabolism
and ATP levels. Our previous study has shown that insulin action
onGLUT4translocationandNHE1activityareintricatelylinked,
demonstrated by the ﬁnding that NHE1 activity is required for
optimal GLUT4 translocation [17]. Cariporide, an NHE inhibitor
[22], prevented the insulin-induced cytosol alkalinization and the
associated insulin-stimulated GLUT4 translocation and glucose
uptake [17].
To explore further the link between NHE1 activity and
GLUT4 translocation, we have examined in the present study the
hypothesis that the NHE1 transporter may also be translocated
in response to the same treatments that stimulate GLUT4
translocation. Based on data from use of the complementary
techniques of confocal microscopy and cell-surface biotiny-
lation, the present study has revealed that there is a signiﬁcant
translocation of NHE1 in cardiomyocytes in responses to insulin,
hypoxia and electrically induced contraction that is similar to the
established translocation process of GLUT4.
EXPERIMENTAL
Reagents
All chemicals, unless otherwise stated, were sourced from
Sigma–Aldrich. Type II collagenase was from Worthington
Biochemicals. Fatty-acid-free BSA was obtained from Roche
Molecular Biochemicals. Insulin was from Novo Nordisk.
Generation and puriﬁcation of rabbit anti-rat NHE1 antibody
For the purpose of generating a speciﬁc antibody recognizing
rat cardiomyocyte NHE1 in immunocytochemistry experiments,
a 503 bp cDNA fragment corresponding to the last 157
amino acids from rat NHE1 (CT-NHE1) was ampliﬁed from
a Marathon (Clontech) rat heart cDNA library prepared as
described previously [23]. The primers used for the
ampliﬁcation contained restriction sites for BglII and EcoRI
(5
 -GtggccAGATCTtacGAGGAAGCCTGGAACCAG-3
  and 5
 -
CtagGAATTCtCTACTGCCCTTTGGGGATG-3
 ) allowing dir-
ect subcloning into pGEX-2T vector (GE Healthcare). The GST
(glutathione transferase)-fusion protein was expressed in the
BL21 strain of Escherichia coli. The GST–NHE1 fusion protein
was puriﬁed by afﬁnity chromatography using glutathione–
Sepharose 4B columns (GE Healthcare) and was then dialysed
against PBS (12.5 mmol/l Na2HPO4 and 154 mmol/l NaCl,
pH 7.2).Puriﬁedproteinwasusedasanantigenforthepreparation
of a polyclonal rabbit serum. Antiserum was generated in New
Zealand White rabbits at Harlan-Sera (UK) using a standard
immunization protocol.
The speciﬁc IgGs were puriﬁed from the immune serum
using an afﬁnity column with immobilized C-terminal NHE1
protein fragment (as above, but lacking the GST fusion, which
was removed by thrombin treatment). The speciﬁcity of the
antibody was tested using whole-cell cardiomyocyte lysates.
The antibody speciﬁcally recognized bands at 110 kDa and
85 kDa corresponding to the two glycosylated forms of NHE1
described previously in cardiomyocytes [24,25].
Cardiomyocyte isolation and stimulation
The study was approved by the University of Bath Institutional
Animal Care and Use Committee. Cardiomyocytes from adult
male Wistar rats (260–280 g) were prepared by collagenase
digestion by use of a previously described method [17], but
with the inclusion of 2 mmol/l inosine in the medium. Cell
suspensions were adjusted to ≈10% cytocrit in KRH (Krebs-
Ringer-Hepes) buffer (128 mmol/l NaCl, 6 mmol/l KCl, 1 mmol/l
Na2HPO4, 0.2 mmol/l NaHPO4, 1.4 mmol/l MgSO4, 1 mmol/l
CaCl2 and 10 mmol/l Hepes, pH 7.4) supplemented with 0.5%
fatty-acid-free BSA, 2 mmol/l pyruvate and 5.5 mmol/l glucose.
With the exception of the hypoxic buffer treatment, cells were
continuously gassed with 95% O2/5% CO2 to pH 7.4throughout
the treatments. For insulin stimulation, cells were incubated with
30 nmol/l insulin for 30 min at 37◦C. Where indicated in the
Figure legends, cardiomyocytes were pre-treated with 100 nmol/l
wortmannin or the equivalent amount of DMSO (0.1%). Stim-
ulationbyhypoxiawasinducedbyincubationinKRHbufferwith
0.5%fatty-acid-freeBSAthathadbeendeoxygenatedfor60 min
and pre-gassed with nitrogen for a further 30 min. The nitrogen
atmosphere was maintained throughout subsequent incubations.
Chemically induced hypoxia was achieved by treating the cells
with 5 μmol/l oligomycin for 60 min. For electrical stimulation
of contraction, 1 ml aliquots of cell suspensions at 37◦C, 10%
cytocrit, were placed in 19 mm diameter polystyrene dishes.
Electrodes (attached to a dish lid) were dipped into the cell
suspension.Cellswerestimulatedatexerciselevelsofcontraction
for 5 min at 100 V, with pulse duration of 1 ms and frequency of
10 Hz. Contraction was monitored under a microscope. For all of
the conditions used in the present study, no more than a 10–20%
decrease of the initial cell viability was observed.
Indirect immunoﬂuorescence microscopy
Stimulated cardiomyocytes were ﬁxed by incubation with 4%
(w/v) paraformaldehyde in KRH buffer for 30 min at room
temperature (20–22◦C), and washed three times with PBS.
The cells were then maintained in blocking buffer [1% (w/v)
BSA and 3% (v/v) goat serum in PBS] for 40 min at room
temperature. For localization of the plasma membrane, ﬁxed cells
were ﬁrst incubated with biotinylated Lens culinaris agglutinin
(LcH) (Sigma) for 30 min at room temperature, washed with
PBS to remove unbound LcH, incubated with streptavidin Alexa
Fluor® 633 conjugate (Molecular Probes) and then washed again
with PBS. Cells were then treated with permeabilization buffer
[0.1% saponin, 1% (w/v) BSA and 3% (v/v) goat serum in
PBS] for 45 min and incubated with 10 μg/ml of rabbit anti-
rat NHE1 antibody overnight at 4◦C. The following day, the
cells were washed in permeabilization buffer, incubated with
Alexa Fluor® 488 goat anti-rabbit IgG (4 μg/ml; Molecular
Probes) for 2 h at room temperature and then washed again
in permeabilization buffer. The co-localization of NHE1 with
GLUT4wasdeterminedincardiomyocytesthatwereincubatedas
above for localization of NHE1, but with the subsequent addition
of 0.1 μg/ml mouse monoclonal anti-GLUT4 antibody (Clone
1F8, Biogenesis) overnight at 4◦C and then Alexa Fluor® 568-
conjugated goat anti-mouse IgG (Molecular Probes) for 2 h at
room temperature with a ﬁnal wash step in permeabilization
buffer.CellsweremountedontoaglasscoverslipwithVectashield
mounting medium (Vector Laboratories).
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Confocal microscopy was performed on a Zeiss LSM 510
META microscope with a 63 × 1.4 NA (numerical aperture)
oil-immersion objective and with dual- or triple-laser excitation
at 458–488, 543 and 633 nm. Images were processed using the
Zeiss LSM Image analysis software and Adobe Photoshop. For
quantiﬁcation of the changes in NHE1 distribution, the intensities
of NHE1 and LcH ﬂuorescence were sampled along radial lines
across the perinuclear area to the sarcolemma and intercalated
disksurfaces.TheproportionofNHE1signalthatoverlappedwith
LcH signal at the cell surfaces was calculated as the percentage
of the total NHE1 sampled along the radial line (Figure 2A).
Cell-surface biotinylation
Levels of NHE1 at the cell surface were assessed by a surface-
protein biotinylation method based on methods described
previously [17,26]. Cells were treated under conditions indicated
in the Figure legends and then cooled to 15◦Cf o r5 m i n .
A cell-impermeant biotin analogue, EZ-Link-Sulfo-NHS-SS-
Biotin (Pierce), was added to the cells at a ﬁnal concentration
of 180 μmol/l for 15 min. The reaction was terminated by
washing the cells with ice-cold KRH and transferring to ice-
cold TES buffer [25 mmol/l Tris/HCl (pH 7.4), 1 mmol/l EDTA
and 0.25 mol/l sucrose] containing protease inhibitors [antipain,
aprotinin, pepstatin A and leupeptin (each at 1 μg/ml) and 100
μmol/l 4-(2-aminoethyl)benzenesulfonyl ﬂuoride)]. Membrane
pellets were prepared by a modiﬁcation of a method that has
been described previously [27]. Brieﬂy, cells were homogenized
in ice-cold TES buffer with 30 strokes of a Potter–Elvenjem
homogenizer.Homogenateswerethensubjectedtocentrifugation
(48000 g for 30 min at 4◦C).
The cell pellets were resuspended in TBS [Tris-buffered
saline; 25 mmol/l Tris/HCl (pH 7.4) and 140 mmol/l NaCl]
and solubilized in lysis buffer [1% (w/v) Triton X-100, 1%
(w/v) sodium deoxycholate, 0.2% SDS, 25 mmol/l Tris/HCl
(pH 7.4) and 140 mmol/l NaCl] containing protease inhibitors
for 2 h at 4◦C. The solubilized membranes were adjusted for
equal protein content and incubated overnight with 50 μlo f
a5 0 % slurry of immobilized streptavidin on agarose beads
(Pierce). After the pull-down, beads were washed twice with
lysis buffer, twice with TBS and once with TE buffer [10
mmol/l Tris/HCl (pH 7.4) and 5 mmol/l EDTA). Proteins were
eluted in SDS/PAGE sample buffer containing 100 mmol/l
dithiothreitol, separated by SDS/PAGE and electrotransferred
on to nitrocellulose membranes. Western blot analysis of
samples precipitated with streptavidin–agarose was performed
using a monoclonal anti-NHE1 antibody (Chemicon, MAB3140
clone 4E9) and a horseradish-peroxidase-conjugated secondary
antibody (Pierce). Signals were detected by ECL (enhanced
chemiluminescence)andwerequantiﬁedusingEpi-ChemiIIDark
Room equipment and LabWorks analysis software (UVP).
A control biotinylation experiment was performed to conﬁrm
the speciﬁcity of the biotinylation of NHE1 by processing the
cardiomyocytes in the same way as described above with
the following modiﬁcations. At the end of the treatments,
the cardiomyocytes were labelled with EZ-Link-Sulfo-NHS-
LC-Biotin (Pierce) instead of EZ-Link-Sulfo-NHS-SS-Biotin
to avoid cleavage of the biotin moiety during the processing
of the samples. The cardiomyocytes were then processed as
describedabove,butthedetergent-solubilizedmembranesamples
were immunoprecipitated with 8 μg of rabbit anti-rat NHE1
antibody overnight. The following day, 20 μlo fa5 0 % slurry
of immobilized Protein A (Pierce) was added to the samples
and incubated for a further 3 h at 4◦C. The immunoprecipitated
NHE1 was then resolved by SDS/PAGE and transferred on to
nitrocellulose for blotting using Extravidin-peroxidase conjugate
(Sigma) to detect the biotinylated proteins.
RESULTS
Subcellular localization of NHE1 in cardiomyocytes
In order to investigate the subcellular localization of NHE1 in
cardiomyocytes, a rat NHE1-speciﬁc antibody was developed.
This antibody was then used to study the subcellular localization
of NHE1 in rat cardiomyocytes by immunoﬂuorescence and
confocal microscopy. In agreement with a previous study
[28], immunoﬂuorescent detection of endogenous NHE1 in
non-stimulated cardiomyocyte membranes revealed that NHE1
preferentially localized at the intercalated disks and the
sarcolemma. NHE1 was also localized in t-tubule regions
identiﬁed as distinctive lines running transversely across the cell
andat90◦ tothelongitudinalregionofsarcolemma(Figure1,left-
hand panels). At the sarcolemma and t-tubules of unstimulated
basal cardiomyocytes, NHE1 was localized in punctate spots
of varying intensity. NHE1 was also seen at deeper perinuclear
locations.
In insulin-stimulated cardiomyocytes, NHE1 distribution at
the sarcolemma was more uniform and homogenous compared
with the punctate sarcolemma distribution observed in basal
cells (Figure 1, left-hand panels). One of the problems
associated with use of confocal microscopy to demonstrate
protein translocation to the limiting cell membranes is that,
on fusion with the limiting membrane, any signal becomes
more delocalized and indistinct. The signal from proteins
inserted into the limiting membrane is difﬁcult to detect
unless the extent of co-localization with a plasma membrane
marker protein is determined. This phenomenon is documented
in numerous studies examining the translocation of GLUT4 in
cardiomyocytes and skeletal muscle cells and cell lines. We have
previously quantiﬁed the translocation of endogenous GLUT4
in cardiomyocytes using immunocytochemical techniques by
comparing the GLUT4 and syntaxin 4 co-localization at the
sarcolemma [17]. To quantitatively evaluate the extent of NHE1
translocation to the sarcolemma we labelled the cell surface with
a biotinylated Lens culinaris agglutinin (LcH) in conjunction
with an Alexa Fluor® 633–streptavidin conjugate. LcH labels
the whole of the sarcolemma, but not the t-tubules (Figure 1,
middle panels). We determined the level of NHE1 signal that
overlapped with that of LcH at the intercalated discs and the
longitudinal edge regions of the sarcolemma and expressed this
level as a percentage of the total NHE1 sampled (Figures 2A and
2B). We did not observe any difference in the pattern of NHE1
redistributionalongthelongitudinaledgeofthesarcolemmawhen
compared with the intercalated discs, so the data from these two
regions of the sarcolemma were combined. The NHE1 levels at
the sarcolemma were found to increase in response to insulin, to
oxidative metabolism stress induced by hypoxia or oligomycin
treatment, and after electrical stimulation to mimic contraction.
For all of the stimuli, an increase of ∼2-fold in the amount of
NHE1 at the sarcolemma was observed (Figure 2B).
Comparison of NHE1 and GLUT4 translocation
NHE1 has been primarily considered to be a plasma membrane
resident protein and has not previously been considered to be
regulated by translocation in cardiomyocytes. We therefore
compared the trafﬁc of NHE1 with that of the well studied
and established process of translocation of the glucose
transporter GLUT4 using comparable immunoﬂuorescent
microscopy techniques. NHE1 and GLUT4 have remarkably
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Figure 1 Immunocytochemical analysis of NHE1 subcellular distribution in
insulin-, hypoxia- and contraction-stimulated cardiomyocytes
Isolated cardiomyocytes were maintained in a basal unstimulated state or incubated in one of
the following conditions: with 30 nmol/l insulin for 30min, in a hypoxic buffer for 15min, with
5 μmol/l oligomycin for 60min, or electrically stimulated to contract for 5min. After the
treatments, cells were washed brieﬂy and ﬁxed with 4% (w/v) paraformaldehyde. After
permeabilization with 0.1% saponin, cells were incubated with rabbit anti-rat NHE1 antibody
and Alexa Fluor® 488-conjugated anti-rabbit IgG (green) (left-hand panels) and visualized
by confocal microscopy. All cells were viewed in approximately the same focal plane. For
quantiﬁcationofthechangesintheNHE1levelsatthesarcolemma,non-permeabilizedcellswere
labelled with LcH and streptavidin–Alexa Fluor® 633 conjugate (red) prior to proceeding to the
immunolabelling of NHE1 (middle panels). Merged images are shown in the right-hand panels.
Control cells were incubated with rabbit anti-rat NHE1 antibody that had been pre-incubated
with the puriﬁed NHE1 fragment that was used as the antigen. Immunoﬂuorescent images
shownarerepresentativefrom8–31cellsexaminedperconditionfromthreetoﬁveindependent
experiments. Scale bars = 20 μm.
similar patterns of distribution throughout the cardiomyocytes
(Figure 3). In the basal state, both proteins are present at
high levels deep within the cell in the perinuclear region and
within punctate structures throughout the cell interior. On
Figure 2 Quantiﬁcation of the extent of redistribution of NHE1 along radial
lines from the perinuclear area to the sarcolemmal surface (SM)
(A)RepresentativeintensitydistributionproﬁlesofNHE1alongradiallinesacrosstheperinuclear
area to the sarcolemma. (B) The proportion of NHE1 that co-localized with LcH (red) at the
sarcolemmal surface was calculated as a percentage of the total NHE1 sampled. Results are
means from 8–31 cells selected at random per condition per experiment and from three to ﬁve
independent experiments. ***P <0.05, compared with the basal value.
insulin stimulation, translocation of both proteins occurs. Close
examination of images suggests that there is less punctate
NHE1 and GLUT4 in the region of the sarcolemma following
stimulation with insulin, but this change in distribution is not
immediately obvious for either transporter protein unless plasma
membrane markers are used. The translocation of GLUT4 in
cardiomyocytes is much more visually apparent using a HA
(haemagglutinin)–GLUT4–GFP (green ﬂuorescent protein)
construct and detection with a ﬂuorescent anti-HA antibody that
recognizes only cell-surface-exposed proteins [29].
Both NHE1 (Figure 1) and GLUT4 [30] translocate to the
limiting membranes of cardiomyocytes in response to insulin
action and stimuli (including hypoxia and contraction) that
impinge upon the energy-status signalling pathway. Both
transporters show a similar pattern of subcellular distribution
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Figure 3 Comparison of NHE1 and GLUT4 subcellular distribution in cardiomyocytes
Isolated cardiomyocytes were maintained in the basal unstimulated state or were incubated with 30 nmol/l insulin for 30min. Cells were then washed, ﬁxed and permeabilized as described in the
Experimental section. The cardiomyocytes were incubated with rabbit anti-rat NHE1 antibody and Alexa Fluor® 488-conjugated anti-rabbit IgG (green) and mouse anti-GLUT4 antibody and Alexa
Fluor® 568-conjugatedanti-mouseIgG(red).Immunolabelledcellswerevisualizedbyconfocalmicroscopy.Allcellswereviewedinapproximatelythesamefocalplane.Thepanelsontheright-hand
side represent zoomed images of square delimited areas indicated in the merged images. Scale bars = 10 μm. Immunoﬂuorescent images shown are representative from ﬁve to ten cells examined
per condition from three to ﬁve independent experiments.
among intracellular compartments both in the perinuclear and
t-tubule regions. However, there is surprisingly little overlap
between the localization of NHE1 and GLUT4 (Figure 3; merged
image, third panel, and zoomed image, fourth panel) particularly
in the basal state. There is some co-localization or overlap of
signals in the perinuclear region, but the distribution of punctate
structures throughout the rest of the cell is distinct and non-
overlapping. It appears that red (GLUT4) and green (NHE1)
localization signals alternate along the radial axis that leads to
the sarcolemma (Figure 3, zoomed images).
Modulation of NHE1 levels at the cell surface of rat cardiomyocytes
in response to insulin
We found that subcellular fractionation of membranes
from cardiomyocytes could not resolve translocation of
either NHE1 or GLUT4 (Supplementary Figure S1 at
http://www.BiochemJ.org/bj/432/bj4320515add.htm). In order
to conﬁrm the immunocytochemical evidence for regulated
translocation of NHE1, we therefore applied a cell-surface
biotinylation technique and used an impermeant cleavable biotin
succinimide reagent Sulfo-NHS-SS-Biotin to covalently tag the
cell-surface protein. Following the pre-incubation treatments
described in the Figure legends, cardiomyocytes were maintained
with these treatments and in the presence of the biotinylating
reagent. After washing away the unbound biotinylation reagent,
membranes were prepared and solubilized and this material was
subjected to streptavidin precipitation and SDS/PAGE resolution
of the precipitated proteins. Western blot analysis with anti-
NHE1 antibody revealed that insulin treatment induced an
increase of the amount of biotinylated NHE1 at the cell surface,
thus conﬁrming the results observed by confocal microscopy
(Figure 4A). The quantiﬁcation of the blotting data indicated
that insulin induced a 2.8-fold increase in the level of NHE1
present in the cell surface of cardiomyocytes. This increase was
complete within 30 min and occurred without any change in
the total level of NHE1 present in the cells as detected, using the
same NHE1 antibody, when blotting the detergent-solubilized
cell membrane control (Figure 4A, lower blot). Insulin is known
to activate multiple signalling pathways in cardiomyocytes.
However, one of the major limbs in insulin signalling is through
the activation of PI3K. To investigate whether PI3K is involved
in the insulin-stimulated increase in cell-surface levels of NHE1,
the biotinylation experiment was performed in the presence of
wortmannin,aPI3Kinhibitor.Wortmanninpre-treatmentblocked
the insulin effect, but did not affect the level of biotinylation of
NHE1 in the basal cells (Figures 4A and 4B).
An alternative method for processing and analysing the extent
of cell-surface biotinylation of NHE1 was also examined. After
labelling with the impermeant biotinylating reagent, solubilized
membranes were subjected to immunoprecipitation with rabbit
anti-rat NHE1 antibody. Control samples were subjected to
the same procedure but using a non-speciﬁc IgG pull-down.
After resolution of the NHE1 by electrophoresis, the levels of
biotinylated NHE1 were detected using Extravidin-peroxidase.
These results (Figure 4C) conﬁrmed the insulin-stimulated
increase of NHE1 at the cell surface and also the speciﬁcity of the
biotinylation technique in detecting variations in NHE1 levels.
Modulation of NHE1 levels at the cell surface of rat cardiomyocytes
in response to oxidative metabolism stress and contraction
Disrupted oxidative metabolism and stimulated contraction alter
the energy status of the cells. Readjustments of cell glucose
metabolism, the AMP/ATP ratio and pHi are necessary after such
treatments. In the case of GLUT4 translocation, the signalling
that follows these stimuli is independent of PI3K and is instead
correlatively associated with increases in AMPK [30]. Treatment
of the cardiomyocytes under hypoxic conditions led to a
3-foldincreaseincell-surfacebiotinylationofNHE1(Figure5A).
Quantiﬁcation of these data (Figure 5B) revealed that this change
was not additive to the insulin effect. When the cells were pre-
treated with insulin prior to hypoxia stimulation, no further
increase in the amount of biotinylated NHE1 was observed.
Similar results were obtained following disruption of the energy
status of the cardiomyocytes by treatment with the mitochondrial
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Figure 4 Treatment with insulin increases the abundance of NHE1 at the
cell surface through a PI3K-dependent mechanism
(A) Isolated cardiomyocytes were incubated for 30min with or without 30 nmol/l insulin.
Where indicated, cells were pre-treated for 15min with 100 nmol/l wortmannin before the
addition of insulin. Cardiomyocytes were then cooled to 15◦C, labelled with 180 μmol/l
Sulfo-NHS-SS-Biotin, washed and membranes prepared. Membranes were solubilized (20μg
ofproteinwastakenforaloadingcontrol),biotinylatedproteinwasprecipitatedwithimmobilized
streptavidin, the precipitated proteins were separated by SDS/PAGE and NHE1 was detected
by Western blot analysis. The blots are representative of ﬁve independent experiments.
(B) Quantiﬁcation data from the Western blot results. The histogram represents the means
+ − S.E.M. from ﬁve independent experiments. *P <0.05, compared with the basal value. (C)
Isolated cardiomyocytes were treated as described in (A) above, but solubilized membrane
proteins were immunoprecipitated either with rabbit anti-rat NHE1 antibody or non-specﬁc IgG
and Protein A.Theprecipitated proteinswereseparated bySDS/PAGE andbiotinylated proteins
were detected by Western blot analysis using an Extravidin-peroxidase conjugate. The blot
representsatypicalresultfromthreeindependentexperiments.IP,immunoprecipitation.For(A)
and (C), the molecular mass in kDa is indicated on the left-hand side.
ATPase(F1)inhibitoroligomycin(Figures5Aand5B).Electrical
stimulation of contraction led to a large 4-fold increase in
NHE1 levels at the cell surface. Wortmannin inhibition of
PI3K activity did not affect the redistribution of NHE1 to the
cell surface that occurred in response to hypoxia, oligomycin
or electrical stimulation of contraction (Figures 5A and 5B),
suggesting that these stimuli affect NHE1 by PI3K-independent
processes. Treatment of cardiomyocytes with Compound C
gave a partial inhibition of the contraction response consistent
with an AMPK involvement (Supplementary Figure S2 at
http://www.BiochemJ.org/bj/432/bj4320515add.htm). However,
Compound C is now known to have quite poor speciﬁcity for
selective inhibition of AMPK signalling [31].
DISCUSSION
In the present study, we have shown for the ﬁrst time that NHE1
levelsatthesarcolemmaofcardiomyocytesareacutelymodulated
in response to stimulation by insulin or through changes in
cell-energy status. Since regulation of NHE1 translocation in
cardiomyocytes is somewhat unexpected, we conﬁrmed the
occurrenceofthisprocessusingthecomplementarytechniquesof
immunoﬂuorescence microscopy and cell-surface biotinylation.
The microscopy is most useful for determining the changes in
localization of NHE1, but is limited by quite poor resolution
of the NHE1 that has become incorporated into the limiting
sarcolemma membrane, unless this distribution is compared with
that of a limiting membrane marker such as LcH.Thecell-surface
biotinylationtechniqueismoreusefulforquantiﬁcationofarange
of responses to modulators and inhibitors.
Other NHE isoforms have been shown to redistribute in
response to signalling. The translocation of NHE3, the apical
epithelial isoform of kidney and intestine, has been most studied.
In the proximal tubule of kidneys, NHE3 redistributes from
the apical plasma membrane to a sub-apical endomembrane
location in response to hypertension or increased intervascular
pressure [32,33]. Increased apical cell-surface expression of
NHE3 in epithelial tissues occurs in response to angiotensin
II, glucocorticoids and insulin, but this may be partly due to
increasedcellularNHE3levels(reviewedin[34]).NHE5isalmost
exclusively expressed in the brain and translocates between the
cell surface and recycling endosomes. This process has been
reported to be mediated by PI3K and to be dependent on an intact
actincytoskeleton[35].Recently,thesmallGTPaseArf6together
with SCAMP2 (secretory carrier-associated membrane protein 2)
was reported to positively regulate the NHE5 recycling process in
neurons [36]. The recruitment of NHE1 may be cell-type-speciﬁc
and dependent on cell-speciﬁc demands for regulation of pHi.
In platelets, there is no detectable translocation of NHE1 and
all the available NHE1 is present at the cell membrane in the
unstimulated basal state [37].
Insulinisknowntoinducecellalkalinizationinculturedmuscle
and adipose cell lines [38,39], adipocytes [18], cardiomyocytes
[17] and erythrocytes [40]. The insulin-induced pH changes have
been linked to activation of the PI3K signalling pathway. We have
previously found that the insulin action on cell alkalinization
in adipocytes [18] and cardiomyocytes [17] is associated with
increased PI3K-dependent GLUT4 translocation. In the present
study, we have demonstrated that the insulin effect on NHE1
translocation is also mediated through the PI3K pathway, as
wortmannincompletelyabolishedtheobservedincreaseinNHE1
levels at the cell surface.
Alterations in the oxidative metabolism of cardiomyocytes
induced by hypoxia or by treatment with the mitochondrial
inhibitor oligomycin also led to elevated levels of NHE1 at the
cellsurface.However,themechanisminvolvedinthisstimulation
is different from the insulin activation process, as wortmannin
did not modify the levels of NHE1 at the cell surface of
cardiomyocytes incubated in hypoxic conditions or treated with
oligomycin. Changes in the AMP/ATP ratio occur in response
to these treatments and are thought, at least in the case of
GLUT4 trafﬁc, to be associated with altered net translocation
and retention at the cell surface. Contraction-induced NHE1
redistribution was also observed to be independent of PI3K
signalling and insensitive to wortmannin inhibition. Contraction-
induced signalling in cardiomyocytes and skeletal muscle only
partly correlates with activation of AMPK [30,41], and the details
of the signalling mechanism by which increased contraction
signals to GLUT4 trafﬁc are currently unclear. No additivity in
the combined responses of NHE1 translocation to insulin and
changes in cell-energy status were observed in cardiomyocytes in
the present study. This contrasts with effects of these stimuli on
GLUT4 translocation. It is possible that only a single limited
population of NHE1 exchangers is available for translocation
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Figure 5 Effects of hypoxia, oligomycin treatment and contraction on the abundance of NHE1 levels at the cell surface
(A) Isolated cardiomyocytes were incubated in hypoxic buffer for 15 min, or treated with 5 μmol/l oligomycin for 60min or were electrically stimulated to contract for 5min. When indicated, cells
were pre-incubated with 100 nmol/l wortmannin for 15min. When the combined effect of insulin stimulation and hypoxia was studied, cardiomyocytes were ﬁrst incubated with 30 nmol/l insulin
for 30min and insulin was then maintained throughout the hypoxic treatment. When the combined effect of insulin and oligomycin treatment was examined, after 30 min of oligomycin treatment
30 nmol/l insulin was added for the remaining 30min of the oligomycin treatment. In each experiment, control cells were left untreated or incubated with 30 nmol/l insulin for 30min. After the
treatments, cardiomyocytes were cooled to 15◦C, labelled without (no biotin control, NBC) or with 180 μmol/l Sulfo-NHS-SS-Biotin. Membrane samples were solubilized (20 μg was taken for
loading control, bottom panel), biotinylated protein was precipitated with immobilized streptavidin, the precipitated proteins were separated by SDS/PAGE and NHE1 was detected by Western blot
analysis (top panel). The blots are representative of three to ﬁve independent experiments. (B) Quantiﬁcation data from Western blot results. The histogram represents the mean + S.E.M from three
to ﬁve independent experiments. *P <0.05, compared with the basal volume.
and that all available NHE1 in this compartment is released in
response to activation of either the PI3K or the AMPK signalling
pathways.
The regulated changes in NHE1 translocation may reﬂect the
need for alkalinization of the cells when increased anaerobic
glucose metabolism and an associated cell acidosis occurs [1].
The processes by which increased translocation of NHE1 occurs
may use the same signalling machinery that is present in
cardiomyocytes for generating increased GLUT4 translocation.
Such a linkage would ensure that the increased glucose
metabolism is associated with restoration of the cell AMP/ATP
ratio and at the same time restoration of normal cellular pHi.
Although the GLUT4 and NHE1 translocations appear to be
triggered by common signalling steps, there must be some
divergenceintherespectivelinksbetweensignallingandtrafﬁcas
intracellular NHE1 and GLUT4 vesicle locations are distinct over
large parts of the cell interior. However, there is some overlap
between intracellular GLUT4 and NHE1 in the perinuclear
regions of the cardiomyocytes, and this may be a site at which
signals to the NHE1 and GLUT4 translocation systems converge.
The role of NHE1 translocation and the relative importance of
altered translocation compared with changes in intrinsic catalytic
activity will need further investigation. Phosphorylation of NHE1
downstream of Akt has been reported to lead to both an increase
[16] in catalytic activity and a decrease [25]. Phosphorylation
of NHE1 downstream of protein kinase A and protein kinase G
leads to decreased catalytic activity, whereas activation of ERK
downstream of protein kinase C and reactive oxygen species
leads to stimulation of catalytic activity [1,42]. Increases in
cellularcalciumalsoleadtoactivationofNHE1intrinsiccatalytic
activity via calmodulin- and CaMKII-dependent mechanisms
[1,43]. Modulation of activity also occurs through alteration of
the extent of interaction with the actin cytoskeleton [13,14]. With
suchﬁnecontrolofcatalyticactivity,thetranslocationmayappear
to be redundant, superﬂuous and unnecessary. However, there is
a very clear need for multiple mechanisms for control of pHi
and NHE1 activity in cardiomyocytes [1]. There are requirements
for very localized changes in pHi [44]. It would be of interest to
determinetheextenttowhichtranslocationofNHE1isassociated
with altered phosphorylation. Mathematical models have been
used to analyse experimental kinetic data on NHE1 activity in
cardiomyocytes and have suggested that catalytic activity alone
may not fully account for the observed changes [45,46]. It would
therefore be useful to incorporate regulated NHE1 translocation
into models of control of total cellular and spatially localized
NHE1 activity.
In addition, phosphorylation-dependent changes in catalytic
activity may exert different temporal control of NHE1 activity
in comparison with translocation. Prolonged treatment with
interferon-γ, in addition to the already reported inhibition of
NHE1 activity, increased NHE1 localization to the cell surface
of human intestinal epithelial cells without affecting the total
amount of NHE1 in the cell [47,48]. The observed increase in the
cell-surface localization of NHE1 was obtained after a prolonged
24 h treatment with interferon-γ. By contrast, in cardiomyocytes
we observed translocation changes in NHE1 within 15–30 min
of treatment, but this change could be associated with even more
immediate changes in catalytic activity. The combination of a
range of control mechanisms would allow temporal versatility in
response to challenges to cell pH homoeostasis.
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Perturbed integration of control of insulin action on GLUT4
translocation, glucose transport, glucose metabolism and NHE1
activity may be important in disease states including Type 2
diabetes. In the Goto–Kakizaki rat model for Type 2 diabetes,
cellular NHE1 levels and activity are activated [49]. However,
decreases in NHE1 activity are associated with decreased
pancreatic insulin secretion occurring in the streptozotocin model
of Type 1 diabetes [50]. Examination of the role of the newly
discovered process of insulin and energy-status control of NHE1
translocation in these disease processes seems warranted. Such
studies may help to further elucidate how GLUT4 translocation,
glucose metabolism, pHi, NHE1 activity and NHE1 translocation
are linked, and may provide insights into how metabolic disease,
including insulin resistance, affects cardiac function.
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Translocation of the Na+/H+ exchanger 1 (NHE1) in cardiomyocyte
responses to insulin and energy-status signalling
Scott P. LAWRENCE1, Geoffrey D. HOLMAN2 and Franc ¸oise KOUMANOV
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FigureS1 DistributionofNHE1andGLUT4inratcardiomyocytemembrane
fractions
Cardiomyocytes were left untreated (B) or incubated with 30 nmol/l insulin for 30min (I).
Trafﬁcking was arrested by the addition of 5 mmol/l sodium azide and cooling to 15◦C.
Cells were homogenized in ice-cold TES buffer [25 mmol/l Tris/HCl (pH7.4), 1 mmol/l EDTA
and 0.25 mol/l sucrose] containing protease inhibitors with 30 strokes of a Potter–Elvenjem
homogenizer. The cell homogenate was subjected to differential centrifugation by an adaptation
from a previously described method [1]. Cell homogenate was spun at 100g for 10min to
pellet unbroken cells, t-tubules and nuclei. The cleared supernatant was spun at 20000g for
30 min to obtain a crude plasma membrane fraction. The resulting supernatant was spun at
48000g for 30min and yielded a pellet of high-density microsomes. The cleared supernatant
was spun at 250000g for 60min and the resulting pellet contained low-density microsomes.
Using this method, the plasma membrane marker Na+/K+ ATPase partitioned in the plasma
membrane fraction by 70% (results not shown). A 20 μg aliquot of each fraction was resolved
by SDS/PAGE, and NHE1 (top panel) or GLUT4 (bottom panel) was detected by Western blot
analysis. The blots are representative of two similar experiments.
1 Present address: Institute for Structural and Molecular Biology, Division of Biosciences, University College London, Gower Street, London WC1E 6BT,
U.K.
2 To whom correspondence should be addressed (email g.d.holman@bath.ac.uk).
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Figure S2 Effect of Compound C on cell-surface NHE1 levels
(A) Isolated cardiomyocytes were incubated for 15min at 37◦C with 1 μmol/l Compound C (Calbiochem) in DMSO (0.1%) or with DMSO alone. Cardiomyocytes were electrically stimulated to
contract for 5min. In each experiment, control cells were left untreated or incubated with 30 nmol/l insulin for 30 min. After the treatments, cardiomyocytes were cooled to 15◦C and labelled with
180 μmol/l Sulfo-NHS-SS-Biotin. Membrane samples were solubilized (20 μg was taken for a loading control; bottom panel), biotinylated protein was precipitated with immobilized streptavidin,
and then the precipitated proteins were separated by SDS/PAGE. NHE1 was detected by Western blot analysis (top panel). The blots are representative of three to ﬁve independent experiments.
(B) Quantiﬁcation of Western blot analysis. Results are the means+S.E.M. from three to ﬁve independent experiments. *P <0.05 compared with contraction.
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